REFERENCES
- Eder, H. A., Russ, E. M., Pritchett, R. A. R., Wilber, M. M. & Barr, D. P. 1955. Proteinlipid relationships in human plasma: In biliary cirrhosis, obstructive jaundice and acute hepatitis. J. clin. Invest. 34, 1147–1162.
- Gjone, E., Javitt, H. N. B. & Blomhoff, J. P. 1973. Studies of LP-X and serum bile acids in Familial LCAT Deficiency.
- Picard, J. & Veissiere, D. 1970. Abnormal serum lipoprotein in cholestasis: identification and isolation. Clin, chim Acta 30, 149–155.
- Ross, A., Murphy, G. M., Wilkinson, P. A., Mills, G. L. & Sherlock, S. 1970. Occurrence of an abnormal lipoprotein in patients with liver disease. Gut 11, 1035–1037.
- Scheuer, P. J. 1968. Liver Biopsy Interpretation. Bailliere, Tindall & Cassell. London.
- Seidel, D. 1971. A new immunochemical technique for a rapid semiquantitative determination of the abnormal lipoprotein (LP-X) characterizing cholestasis. Clin chim. Acta 31, 225 229.
- Seidel, D., Schmitt, E. A. & Alaupovic, P. 1970. An abnormal low density lipoprotein in obstructive jaundice II: Significance in the differential diagnosis of jaundice. Germ. med. Mill. 15, 671–675.
- Switzer, S. 1967. Plasma lipoproteins in liver disease. I. lmmunologically distinct low-density lipoproteins in patients with biliary obstruction. J. clin. Invest. 46, 1855–1866.
- Torsvik, H., Berg, K., Magnani, H. N., McConathy, W. J., Alaupovic, P. & Gjone, E. 1972. Identification of the abnormal cholestatic lipoprotein (LP-X) in Familial LCAT Deficiency. FEBS Letters 24, 165–168.